Brainsway Ltd. ADR

Brainsway Ltd. operates as a medical device company, specializing in the development of advanced neurostimulation treatments for various mental health disorders. The company is renowned for its use of proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive therapeutic modality designed to target specific areas of the brain associated with neurological and psychological conditions. Brainsway's Deep TMS systems are utilized to address diverse mental health issues such as depression, obsessive-compulsive disorder (OCD), and smoking addiction. As an American Depositary Receipt (ADR), Brainsway Ltd. is made available on a United States exchange, allowing U.S. investors the opportunity to invest in the company while its headquarters remain overseas in Israel. Brainsway's innovative approach contributes significantly to the medical device industry, particularly within the mental health sector, where there is a growing demand for alternative treatments. The company's technology supports advancements in personalized medicine, providing healthcare providers with targeted treatment options that improve patient outcomes and expand therapeutic possibilities in neuroscience and psychiatry.

Sector

Healthcare

Industry

Medical Devices

Employees

129

Headquarters

Jerusalem, Israel

Website

www.brainsway.com